FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/077307 [Registered on: 25/11/2024] Trial Registered Prospectively
Last Modified On: 22/11/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Inspiratory and Expiratory Muscle Training Protocols on Dialysis Dependent Chronic Kidney Disease Patients 
Scientific Title of Study   Efficacy of different Inspiratory and Expiratory Muscle Training protocols on Cardiopulmonary Parameters in Dialysis Dependent Chronic Kidney Disease Patients: A Comparative Study  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Neha Reyalch 
Designation  Assistant Professor 
Affiliation  S.G.T University 
Address  Faculty of Physiotherapy SGT University, Gurugram

Gurgaon
HARYANA
122006
India 
Phone  8826043916  
Fax    
Email  nehareyalch09@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Neha Reyalch 
Designation  Assistant Professor 
Affiliation  S.G.T University 
Address  Faculty of Physiotherapy SGT University, Gurugram

Gurgaon
HARYANA
122006
India 
Phone  8826043916  
Fax    
Email  nehareyalch09@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Neha Reyalch 
Designation  Assistant Professor 
Affiliation  S.G.T University 
Address  Faculty of Physiotherapy SGT University, Gurugram

Gurgaon
HARYANA
122006
India 
Phone  8826043916  
Fax    
Email  nehareyalch09@gmail.com  
 
Source of Monetary or Material Support  
S.G.T University 
 
Primary Sponsor  
Name  SGT University 
Address  Budhera Gurugram  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Neha Reyalch  SGT Hospital Gurugram  SGT University Budhera Gurugram
Gurgaon
HARYANA 
8826043916

nehareyalch09@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J989||Respiratory disorder, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Group 1-Inspiratory Muscle Training + Pulmonary Rehab   Patient Will Perform Inspiratory Muscle Training along with Pulmonary Rehab which includes aerobic Training and Chest Expansions Exercises 
Intervention  GROUP 2- Expiratory Muscle Training + Pulmonary rehab  Patient will perform the PEP Expiratory Muscle Training along with Pulmonary rehab which includes aerobic training and chest Expansion Exercise 
Comparator Agent  GROUP 3 - Conventional Pulmonary rehab  1. Deep breathing exercises 2. Spirometry 3. Chest expansion exercises  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patients with chronic kidney disease who are on hemodialysis for more than 3 months with or without cardiopulmonary complications.
2. The study will include men and women older than 18 years.
 
 
ExclusionCriteria 
Details  1. History of arrhythmias (6 months)
2. Unstable angina.
3. Severe lung carcinoma
4. Severe valve disease
5. Spinal cord injured patient
6. Patient with lower limb amputation
7. Decompensated Diabetes Mellitus and Hypertension
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
1 Inspiratory Muscle strength
2 Expiratory Muscle strength 
Day 1 Assessment
4th Week Assessment
8th Week Assessment 
 
Secondary Outcome  
Outcome  TimePoints 
1. Diaphragm thickness
2. Pulmonary function test
3. liver function test
4. kidney function test
5. Glomerular filtration rat
6. 6 min walk test & vo2 max
7. Quality of life 
Day 1 Assessment
4th Week Assessment
8th Week Assessment 
 
Target Sample Size   Total Sample Size="48"
Sample Size from India="48" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   09/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [nehareyalch09@gmail.com].

  6. For how long will this data be available start date provided 30-11-2025 and end date provided 31-01-2026?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  
CKD is not only a major risk factor for dialysis but also increased the risk of cardiovascular, respiratory, musculoskeletal, immune, endocrine and metabolic system. The reduced lung function leads to endothelial alteration. The cardiovascular diseases are collectively the main cause of death in patients with undergoing hemodialysis. The reduction in the inspiratory and expiratory muscle strength, is evaluated by maximum inspiratory pressure(MIP). Thus inspiratory muscle training could improve functional capacity in hemodialysis patient. However, the effect of threshold IMT and threshold PEP IMT with integrated renal rehabilitation have not yet compared with the cardiopulmonary complication in CKD patient.

Null Hypothesis

H01.   The effect of Threshold IMT with integrated rehabilitation will not produce any change in the muscle strength, PFT, GFR, cardiorespiratory fitness in dialysis depended CKD patient.

H12   The effect of Threshold PEP IMT with integrated rehabilitation will not produce any change in the muscle strength, PFT, GFR, LFT, KFT, Diaphragm thickness and cardiorespiratory fitness in dialysis-dependent CKD patients.

H2 The effect of threshold IMT and threshold PEP IMT with integrated renal rehabilitation there will be no comparison in the muscle strength, PFT, GFR, LFT, KFT, Diaphragm thickness and cardiopulmonary fitness in dialysis-dependent CKD patients.

Alternate Hypothesis

H1. The effect of Threshold IMT with integrated rehabilitation will produce changes in the muscle strength, PFT, GFR, LFT, KFT, Diaphragm thickness and cardiorespiratory fitness in dialysis-dependent CKD patients.

HThe effect of Threshold PEP IMT with integrated rehabilitation will produce changes in the muscle strength, PFT, GFR, LFT, KFT, Diaphragm thickness and cardiorespiratory fitness in dialysis-dependent CKD patients.

H3 The effect of threshold IMT and threshold PEP IMT with integrated renal rehabilitation there will be a comparison in the muscle strength, PFT, GFR, LFT, KFT, Diaphragm thickness and cardiopulmonary fitness in dialysis-dependent CKD patients.

 
Close